- Envoy Medical implemented a 1-for-10 reverse stock split effective October 26, 2026.
- The action is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- Trading begins on a split-adjusted basis under new CUSIP 29415V307.
?? Negative AI Sentiment (-3.5 / 10)